Adequacy of Self-Performed SARS-CoV-2 Rapid Antigen-Detection Testing for Mass Screening in Workplace

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MAY 6, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.10559?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=050622

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Researchers assessed the adequacy of serial self-performed SARS-CoV-2 rapid antigen detection tests (RADT) performed by untrained persons in the workplace, in terms of the frequency of correct execution of procedural steps and accurate interpretation of the range of possible RADT results.

Authors: Cedric P. Yansouni, M.D., of the Optilab Montreal–McGill University Health Centre in Montreal, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.10559)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.